(Q37821331)

23 August 2017

1 reference

title

Iron chelation and neuroprotection in neurodegenerative diseases (English)

1 reference

23 August 2017

1 reference

2

Joseph Jankovic

1 reference

23 August 2017

Xuping Li

1

1 reference

PubMed ID

21161300

23 August 2017

Weidong Le

series ordinal

3

1 reference

23 August 2017

16 December 2010

1 reference

Journal of Neural Transmission

23 August 2017

1 reference

23 August 2017

118

1 reference

23 August 2017

3

1 reference

23 August 2017

473-477

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-010-0518-0

23 August 2017

0 references

cites work

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Ferritins: a family of molecules for iron storage, antioxidation and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Brain iron homeostasis and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

What is the function of neuroglobin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Iron: the Redox-active center of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Neuroglobin expression in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Regulation of apoptosis-associated lysosomal membrane permeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Role of oxidative stress in paraquat-induced dopaminergic cell degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Iron storage within dopamine neurovesicles revealed by chemical nano-imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Genetics of iron regulation and the possible role of iron in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Iron, the substantia nigra and related neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Iron: a new target for pharmacological intervention in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0518-0

Iron, neuroinflammation, and Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators

1 reference

12 December 2020

Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.

1 reference

12 December 2020

New face of neuromelanin.

1 reference

12 December 2020

Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.

1 reference

12 December 2020

Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism

1 reference

12 December 2020

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

12 December 2020

Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.

1 reference

12 December 2020

10.1007/S00702-010-0518-0

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21161300